文献速递类风湿关节炎

类风湿关节炎不同治疗成功类型的基线预测因素

Baseline predictors of different types of treatment success in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2021-10-04

该研究基于ASPIRE试验(主分析)及ATTRACT和GO-BEFORE试验(验证),分析患者与疾病特征、核心指标及复合指数对类风湿关节炎不同治疗结局的预测作用。结果显示基线疾病活动度低(除急性期反应物外)与状态结局(如SDAI的LDA)相关,而基线值高与变化结局相关;较短病程、男性及较低疾病活动度组合对状态结局预测最佳,反应结局无一致显著预测因素(C反应蛋白除外,基线高者反应更好)。

要点

  • 基线疾病活动度低(除急性期反应物)预测状态结局(如SDAI的LDA),而基线值高预测变化结局。
  • 较短病程、男性及较低疾病活动度组合对状态结局预测最佳。
  • 反应结局无一致显著预测因素,但基线C反应蛋白高与更好反应相关。

核心结论

  • 类风湿关节炎治疗成功的预测有限,尤其在早期RA中,较低基线疾病活动度可预测状态目标达成。
  • 性别和病程可能提高状态目标的预测性。

研究设计与样本

  • 使用三项类风湿关节炎试验数据,ASPIRE用于主分析,ATTRACT和GO-BEFORE用于验证。
  • 分析患者和疾病特征、核心指标及复合指数对不同结局(反应、状态、变化)的预测作用。

主要发现

  • 基线疾病活动度组分(除急性期反应物外)较低与状态结局(如SDAI的LDA)达成相关。
  • 基线值较高与变化结局(如SDAI绝对变化)达成相关。
  • 多变量分析显示较短病程、男性性别和较低疾病活动度组合对状态结局预测最佳。
  • 反应结局无一致显著预测因素,但基线C反应蛋白较高与更好反应相关。

关键数值与推荐

  • 状态结局包括缓解或低疾病活动度(LDA),变化结局为度量尺度的数值变化。
  • 反应结局为达到相对反应边际的患者百分比。

临床怎么用

  • 在早期RA中,可依据较低基线疾病活动度预测状态目标达成,性别和病程可辅助预测。
  • 临床试验中可协调纳入人群和结局选择以提高效率。

局限性

  • 预测治疗成功在RA中整体有限。
  • 反应结局缺乏一致显著预测因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To perform a comprehensive analysis on predictors of achieving disease activity outcomes by change, response and state measures. METHODS: We used data from three rheumatoid arthritis (RA) trials (one for main analysis, two for validation) to analyse the effect of patient and disease characteristics, core set measure and composite indices on the achievement of different outcomes: response outcomes (% of patients achieving a relative response margin); state outcomes (remission or low disease activity, LDA) and change outcomes (numerical change on metric scales). RESULTS: We included patients from the ASPIRE trial (for analysis) and from the ATTRACT and GO-BEFORE trials (for validation). While lower disease activity components at baseline-except acute phase reactants-were associated with achievement of state outcomes (such as LDA by the Simplified Disease Activity Index, SDAI), higher baseline values were associated with change outcomes (such as SDAI absolute change). A multivariate analysis of the identified predictors of state outcomes identified best prediction by a combination of shorter disease duration, male gender and lower disease activity. For prediction of response, no consistently significant predictors were found, again, with exception of C reactive protein, for which higher levels at baseline were associated with better responses. CONCLUSION: Prediction of treatment success is limited in RA. Particularly in early RA, prediction of state targets can be achieved by lower baseline levels of diseases activity. Gender and disease duration may improve the predictability of state targets. In clinical trials, included populations and choice of outcomes can be coordinated to maximise efficiency from these studies.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Capelusnik D, Aletaha D. Baseline predictors of different types of treatment success in rheumatoid arthritis. Ann Rheum Dis. 2021. PMID: 34607792. doi:10.1136/annrheumdis-2021-220853

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。